Prescription Drug Monitoring Programs and Opioid Prescriptions for Disability Conditions
- PDF / 827,523 Bytes
- 14 Pages / 595.276 x 790.866 pts Page_size
- 18 Downloads / 219 Views
ORIGINAL RESEARCH ARTICLE
Prescription Drug Monitoring Programs and Opioid Prescriptions for Disability Conditions Orgul Ozturk1 · Yuan Hong2 · Suzanne McDermott3 · Margaret Turk4 Accepted: 29 October 2020 © Springer Nature Switzerland AG 2020
Abstract Background There are variants of prescription drug monitoring programs (PDMPs) and different groups of patients who are prescribed opioids. Patients with disabilities and those with chronic conditions might have different experiences in physician prescribing practices for opioids, when compared to a comparison group without these conditions. Objective To determine differences in opioid prescriptions related to PDMPs for people without cancer-related pain and with disability conditions compared to other adult opioid users without cancer, using a national database. Method Opioid users were identified from the US Medical Expenditure Panel Survey. Disability groups were defined by diagnosis codes related to longstanding physical disability and inflammatory conditions. Our analyses used an event study framework and a difference-in-differences approach. Results During a two-year panel period, PDMPs did not reduce opioid prescriptions for individuals with disabilities who use opioids. Our data show that individuals with disabilities who use opioids, on average, have a higher incidence of continuous opioid use and significantly greater amounts prescribed compared to other adults who have opioid prescriptions. Conclusion PDMPs do not appear to affect prescribers’ initial or ongoing use of opioids for individuals with longstanding physical disabilities and those with inflammatory conditions. Thus, these adults have greater exposure to opioids, compared to other adults who were prescribed opioids. Key Points for Decision Makers
* Orgul Ozturk [email protected] Yuan Hong [email protected] Suzanne McDermott [email protected] Margaret Turk [email protected] 1
Economics Department, Darla Moore School of Business, University of South Carolina, Columbia 803‑4636168, USA
2
Department of Epidemiology and Biostatistics Arnold School of Public Health, University of South Carolina University of South Carolina, Columbia, USA
3
Department of Environmental, Occupational, and Geospatial Health Sciences, School of Public Health and Health Policy, City University of New York, New York, USA
4
Department of Physical Medicine and Rehabilitation, Upstate Medical University, Syracuse, USA
Adults with longstanding disability and those with inflammatory conditions had higher levels of continuous opioid prescriptions, compared to their peers, in nationally representative data from 2000–2014 Adults with longstanding disability and those with inflammatory conditions were prescribed higher doses and had more refills of opioids compared to others, over the 2-year observation period. Prescription drug monitoring programs (PDMP) did not impact the prescribing patterns for adults with longstanding physical disability and those with inflammatory conditions.
Vol.:
Data Loading...
